Prof. Dr. Dr. Flavio Forrer
Leiter Nuklearmedizin
Leitende(r) Arzt/Ärztin
Radiologie und Nuklearmedizin · Dept. IV
Early response monitoring during [Lu]Lu-PSMA I&T therapy with quantitated SPECT/CT predicts overall survival of mCRPC patients: subgroup analysis of a Swiss-wide prospective registry study.
Neubauer M, Nicolas G, Bauman A, Fani M, Nitzsche E, Afshar-Oromieh A, Forrer F, Rentsch C, Stenner-Liewen F, Templeton A, Schäfer N, Wild D, Chirindel A, all investigators on behalf of the SSNM Therapy Working Group. Early response monitoring during [Lu]Lu-PSMA I&T therapy with quantitated SPECT/CT predicts overall survival of mCRPC patients: subgroup analysis of a Swiss-wide prospective registry study. Eur J Nucl Med Mol Imaging 2023
01.12.2023Early response monitoring during [Lu]Lu-PSMA I&T therapy with quantitated SPECT/CT predicts overall survival of mCRPC patients: subgroup analysis of a Swiss-wide prospective registry study.
01.12.2023Eur J Nucl Med Mol Imaging 2023
Neubauer Moritz C, Nicolas Guillaume, Bauman Andreas, Fani Melpomeni, Nitzsche Egbert U, Afshar-Oromieh Ali, Forrer Flavio, Rentsch Cyrill A, Stenner-Liewen Frank, Templeton Arnoud J, Schäfer Niklaus G, Wild Damian, Chirindel Alin, all investigators on behalf of the SSNM Therapy Working Group
Joint EANM/SNMMI procedure guideline for the use of Lu-labeled PSMA-targeted radioligand-therapy (Lu-PSMA-RLT).
Kratochwil C, Fendler W, Eiber M, Hofman M, Emmett L, Calais J, Osborne J, Iravani A, Koo P, Lindenberg L, Baum R, Bozkurt M, Delgado Bolton R, Ezziddin S, Forrer F, Hicks R, Hope T, Kabasakal L, Konijnenberg M, Kopka K, Lassmann M, Mottaghy F, Oyen W, Rahbar K, Schöder H, Virgolini I, Bodei L, Fanti S, Haberkorn U, Hermann K. Joint EANM/SNMMI procedure guideline for the use of Lu-labeled PSMA-targeted radioligand-therapy (Lu-PSMA-RLT). Eur J Nucl Med Mol Imaging 2023; 50:2830-2845.
29.05.2023Joint EANM/SNMMI procedure guideline for the use of Lu-labeled PSMA-targeted radioligand-therapy (Lu-PSMA-RLT).
29.05.2023Eur J Nucl Med Mol Imaging 2023; 50:2830-2845
Kratochwil Clemens, Fendler Wolfgang Peter, Eiber Matthias, Hofman Michael S, Emmett Louise, Calais Jeremie, Osborne Joseph R, Iravani Amir, Koo Phillip, Lindenberg Liza, Baum Richard, Bozkurt Murat Fani, Delgado Bolton Roberto C, Ezziddin Samer, Forrer Flavio, Hicks Rodney J, Hope Thomas A, Kabasakal Levent, Konijnenberg Mark, Kopka Klaus, Lassmann Michael, Mottaghy Felix M, Oyen Wim J G, Rahbar Kambiz, Schöder Heiko, Virgolini Irene, Bodei Lisa, Fanti Stefano, Haberkorn Uwe, Hermann Ken
Variations in Radioiodine Therapy in Europe - Decision-Making after Total Thyroidectomy
Forrer F, Zerdoud S, Vrachimis A, Petranovic Ovčaričekj P, Mihailovic J, Luster M, Iakovou I, Hoffmann M, Giovanella L, Maas O, Fischer G, Putora P. Variations in Radioiodine Therapy in Europe - Decision-Making after Total Thyroidectomy. Oncology 2021
17.11.2021Variations in Radioiodine Therapy in Europe - Decision-Making after Total Thyroidectomy
17.11.2021Oncology 2021
Forrer Flavio, Zerdoud Slimane, Vrachimis Alexis, Petranovic Ovčaričekj Petra, Mihailovic Jasna, Luster Markus, Iakovou Ioannis, Hoffmann Martha, Giovanella Luca, Maas Ole, Fischer Galina, Putora Paul Martin
Impact of the COVID-19 pandemic on nuclear medicine departments in Europe
Moreira A, Nazarenko S, Mihailovic J, Bar-Sever Z, O'Connell M, Miladinova D, Graham R, Giubbini R, Kaliská L, Rozić D, Krause B, Gallowitsch H, Györke T, Sediene S, Rumyantsev P, Wadsak W, Garcia-Cañamaque L, Simanek M, Mussalo H, Jamar F, Ozcan Z, Piciu D, Als C, Franceschi M, Trägårdh E, Zagar I, Sowa-Staszczak A, Cachin F, Bennink R, Forrer F, Adamsen T, Fotopolous A, Kalnina M, Jensen L, Kunikowska J. Impact of the COVID-19 pandemic on nuclear medicine departments in Europe. Eur J Nucl Med Mol Imaging 2021; 48:3361-3364.
01.01.2021Impact of the COVID-19 pandemic on nuclear medicine departments in Europe
01.01.2021Eur J Nucl Med Mol Imaging 2021; 48:3361-3364
Moreira Ana Paula, Nazarenko Sergei, Mihailovic Jasna, Bar-Sever Zvi, O'Connell Martin, Miladinova Daniela, Graham Richard, Giubbini Raffaele, Kaliská Lucia, Rozić Damir, Krause Bernd J, Gallowitsch Hans-Jürgen, Györke Tamás, Sediene Severina, Rumyantsev Pavel, Wadsak Wolfgang, Garcia-Cañamaque Lina, Simanek Milan, Mussalo Hanna, Jamar François, Ozcan Zehra, Piciu Doina, Als Claudine, Franceschi Maja, Trägårdh Elin, Zagar Ivana, Sowa-Staszczak Anna, Cachin Florent, Bennink Roel, Forrer Flavio, Adamsen Tom Christian, Fotopolous Andreas, Kalnina Marika, Jensen Lars Thorbjørn, Kunikowska Jolanta
Genetic heterogeneity highlighted by differential FDG-PET response in diffuse large B-cell lymphoma
Araf S, Fitzgibbon J, Okosun J, Johnson P, Davies A, Rimsza L, Scott D, Graham T, Barrington S, Forrer F, Kumar E, Cogliatti S, Wang J, Bewicke-Copley F, Korfi K, Fehr M. Genetic heterogeneity highlighted by differential FDG-PET response in diffuse large B-cell lymphoma. Haematologica 2020; 105:318-321.
09.04.2020Genetic heterogeneity highlighted by differential FDG-PET response in diffuse large B-cell lymphoma
09.04.2020Haematologica 2020; 105:318-321
Araf Shamzah, Fitzgibbon Jude, Okosun Jessica, Johnson Peter, Davies Andrew, Rimsza Lisa M, Scott David W, Graham Trevor A, Barrington Sally F, Forrer Flavio, Kumar Emil, Cogliatti Sergio B., Wang Jun, Bewicke-Copley Findlay, Korfi Koorosh, Fehr Martin
Early Prediction of Treatment Response of Neuroendocrine Hepatic Metastases after Peptide Receptor Radionuclide Therapy with Y-DOTATOC Using Diffusion Weighted and Dynamic Contrast-Enhanced MRI
Weikert T, Maas O, Haas T, Klarhöfer M, Bremerich J, Forrer F, Sauter A, Sommer G. Early Prediction of Treatment Response of Neuroendocrine Hepatic Metastases after Peptide Receptor Radionuclide Therapy with Y-DOTATOC Using Diffusion Weighted and Dynamic Contrast-Enhanced MRI. Contrast Media Mol Imaging 2019; 2019:1517208.
11.11.2019Early Prediction of Treatment Response of Neuroendocrine Hepatic Metastases after Peptide Receptor Radionuclide Therapy with Y-DOTATOC Using Diffusion Weighted and Dynamic Contrast-Enhanced MRI
11.11.2019Contrast Media Mol Imaging 2019; 2019:1517208
Weikert Thomas, Maas Ole, Haas Tanja, Klarhöfer Markus, Bremerich Jens, Forrer Flavio, Sauter Alexander Walter, Sommer Gregor
EANM procedure guidelines for radionuclide therapy with Lu-labelled PSMA-ligands (Lu-PSMA-RLT)
Kratochwil C, Lassmann M, Mottaghy F, Oyen W, Rahbar K, Schöder H, Virgolini I, Wester H, Bodei L, Fanti S, Haberkorn U, Kopka K, Konijnenberg M, Kabasakal L, Fendler W, Eiber M, Baum R, Bozkurt M, Czernin J, Delgado Bolton R, Ezziddin S, Forrer F, Hicks R, Hope T, Herrmann K. EANM procedure guidelines for radionuclide therapy with Lu-labelled PSMA-ligands (Lu-PSMA-RLT). Eur J Nucl Med Mol Imaging 2019; 46:2536-2544.
22.08.2019EANM procedure guidelines for radionuclide therapy with Lu-labelled PSMA-ligands (Lu-PSMA-RLT)
22.08.2019Eur J Nucl Med Mol Imaging 2019; 46:2536-2544
Kratochwil Clemens, Lassmann Michael, Mottaghy Felix M, Oyen Wim, Rahbar Kambiz, Schöder Heiko, Virgolini Irene, Wester Hans-Jürgen, Bodei Lisa, Fanti Stefano, Haberkorn Uwe, Kopka Klaus, Konijnenberg Mark, Kabasakal Levant, Fendler Wolfgang Peter, Eiber Matthias, Baum Richard, Bozkurt Murat Fani, Czernin Johannes, Delgado Bolton Roberto C, Ezziddin Samer, Forrer Flavio, Hicks Rodney J, Hope Thomas A, Herrmann Ken
Myeloid neoplasms after chemotherapy and PRRT: myth and reality
Bodei L, Modlin I, Luster M, Forrer F, Cremonesi M, Hicks R, Ezziddin S, Kidd M, Chiti A. Myeloid neoplasms after chemotherapy and PRRT: myth and reality. Endocr Relat Cancer 2016; 23:C1-7.
28.06.2016Myeloid neoplasms after chemotherapy and PRRT: myth and reality
28.06.2016Endocr Relat Cancer 2016; 23:C1-7
Bodei Lisa, Modlin Irvin M, Luster Markus, Forrer Flavio, Cremonesi Marta, Hicks Rodney J, Ezziddin Samer, Kidd Mark, Chiti Arturo
Bilaterale Halsschwellung bei einer jungen Frau
Koster-Rusch A, Capraro J, Nagel W, Clerici T, Stöckli S, Forrer F, Brändle M, Bilz S. Bilaterale Halsschwellung bei einer jungen Frau. Swiss Medical Forum 2016; 16:253-255.
08.04.2016Bilaterale Halsschwellung bei einer jungen Frau
08.04.2016Swiss Medical Forum 2016; 16:253-255
Koster-Rusch Anita, Capraro Joel, Nagel Wolfgang, Clerici Thomas, Stöckli Sandro, Forrer Flavio, Brändle Michael, Bilz Stefan
Successful Medical Treatment of Adult Nesidioblastosis With Pasireotide over 3 Years: A Case Report
Schwetz V, Sourij H, Treiber G, Pieber T, Forrer F, Perren A, Lackner C, Kump P, Horvath K, Mader J. Successful Medical Treatment of Adult Nesidioblastosis With Pasireotide over 3 Years: A Case Report. Medicine (Baltimore) 2016; 95:e3272.
01.04.2016Successful Medical Treatment of Adult Nesidioblastosis With Pasireotide over 3 Years: A Case Report
01.04.2016Medicine (Baltimore) 2016; 95:e3272
Schwetz Verena, Sourij Harald, Treiber Gerlies, Pieber Thomas R, Forrer Flavio, Perren Aurel, Lackner Carolin, Kump Patrizia, Horvath Karl, Mader Julia K
90Y-DOTATOC as a Therapeutic Option for Complex Recurrent or Progressive Meningiomas
Gerster-Gilliéron K, Forrer F, Maecke H, Mueller-Brand J, Merlo A, Cordier D. 90Y-DOTATOC as a Therapeutic Option for Complex Recurrent or Progressive Meningiomas. J Nucl Med 2015; 56:1748-51.
20.08.201590Y-DOTATOC as a Therapeutic Option for Complex Recurrent or Progressive Meningiomas
20.08.2015J Nucl Med 2015; 56:1748-51
Gerster-Gilliéron Karine, Forrer Flavio, Maecke Helmut, Mueller-Brand Jan, Merlo Adrian, Cordier Dominik
SPECT/CT for the assessment of painful knee prosthesis
Forrer F, Hirschmann M, Rasch H. SPECT/CT for the assessment of painful knee prosthesis. Nucl Med Commun 2014; 35:782.
01.07.2014SPECT/CT for the assessment of painful knee prosthesis
01.07.2014Nucl Med Commun 2014; 35:782
Forrer Flavio, Hirschmann Michael T, Rasch Helmut F
Glucagon-like peptide-1 receptor imaging for the localisation of insulinomas: a prospective multicentre imaging study
Christ E, Reubi J, Perren A, Gloor B, Seufert J, Ell P, Stettler C, Fischli S, Clerici T, Brändle M, Caplin M, Nicolas G, Béhé M, Ederer S, Wild D, Forrer F. Glucagon-like peptide-1 receptor imaging for the localisation of insulinomas: a prospective multicentre imaging study. Lancet Diabetes Endocrinol 2013; 1:115-22.
25.07.2013Glucagon-like peptide-1 receptor imaging for the localisation of insulinomas: a prospective multicentre imaging study
25.07.2013Lancet Diabetes Endocrinol 2013; 1:115-22
Christ Emanuel, Reubi Jean Claude, Perren Aurel, Gloor Beat, Seufert Jochen, Ell Peter J, Stettler Christoph, Fischli Stefan, Clerici Thomas, Brändle Michael, Caplin Martyn E, Nicolas Guillaume, Béhé Martin, Ederer Susanne, Wild Damian, Forrer Flavio
4D-SPECT/CT in orthopaedics: a new method of combined quantitative volumetric 3D analysis of SPECT/CT tracer uptake and component position measurements in patients after total knee arthroplasty
Rasch H, Falkowski A, Forrer F, Henckel J, Hirschmann M. 4D-SPECT/CT in orthopaedics: a new method of combined quantitative volumetric 3D analysis of SPECT/CT tracer uptake and component position measurements in patients after total knee arthroplasty. Skeletal Radiol 2013; 42:1215-23.
22.05.20134D-SPECT/CT in orthopaedics: a new method of combined quantitative volumetric 3D analysis of SPECT/CT tracer uptake and component position measurements in patients after total knee arthroplasty
22.05.2013Skeletal Radiol 2013; 42:1215-23
Rasch Helmut, Falkowski Anna L, Forrer Flavio, Henckel Johann, Hirschmann Michael T
Radioimmunotherapy with 177Lu-DOTA-rituximab: final results of a phase I/II Study in 31 patients with relapsing follicular, mantle cell, and other indolent B-cell lymphomas
Forrer F, Oechslin-Oberholzer C, Campana B, Herrmann R, Maecke H, Mueller-Brand J, Lohri A. Radioimmunotherapy with 177Lu-DOTA-rituximab: final results of a phase I/II Study in 31 patients with relapsing follicular, mantle cell, and other indolent B-cell lymphomas. J Nucl Med 2013; 54:1045-52.
09.04.2013Radioimmunotherapy with 177Lu-DOTA-rituximab: final results of a phase I/II Study in 31 patients with relapsing follicular, mantle cell, and other indolent B-cell lymphomas
09.04.2013J Nucl Med 2013; 54:1045-52
Forrer Flavio, Oechslin-Oberholzer Catharina, Campana Benedetta, Herrmann Richard, Maecke Helmut R, Mueller-Brand Jan, Lohri Andreas
Is there need for radioimmunotherapy? results of a phase I/II study in patients with indolent B-cell lymphomas using lutetium-177-DOTA-rituximab
Forrer F, Oechslin-Oberholzer C, Campana B, Maecke H, Mueller-Brand J, Lohri A. Is there need for radioimmunotherapy? results of a phase I/II study in patients with indolent B-cell lymphomas using lutetium-177-DOTA-rituximab. Q J Nucl Med Mol Imaging 2012; 56:544-50.
01.12.2012Is there need for radioimmunotherapy? results of a phase I/II study in patients with indolent B-cell lymphomas using lutetium-177-DOTA-rituximab
01.12.2012Q J Nucl Med Mol Imaging 2012; 56:544-50
Forrer Flavio, Oechslin-Oberholzer C, Campana B, Maecke H, Mueller-Brand J, Lohri A
Preoperative staging of non-small-cell lung cancer: comparison of whole-body diffusion-weighted magnetic resonance imaging and 18F-fluorodeoxyglucose-positron emission tomography/computed tomography
Sommer G, Wiese M, Winter L, Lenz C, Klarhöfer M, Forrer F, Lardinois D, Bremerich J. Preoperative staging of non-small-cell lung cancer: comparison of whole-body diffusion-weighted magnetic resonance imaging and 18F-fluorodeoxyglucose-positron emission tomography/computed tomography. Eur Radiol 2012; 22:2859-67.
09.07.2012Preoperative staging of non-small-cell lung cancer: comparison of whole-body diffusion-weighted magnetic resonance imaging and 18F-fluorodeoxyglucose-positron emission tomography/computed tomography
09.07.2012Eur Radiol 2012; 22:2859-67
Sommer Gregor, Wiese Mark, Winter Leopold, Lenz Claudia, Klarhöfer Markus, Forrer Flavio, Lardinois Didier, Bremerich Jens
Peptide receptor radionuclide therapy with somatostatin analogues in neuroendocrine tumors
Giovacchini G, Nicolas G, Forrer F. Peptide receptor radionuclide therapy with somatostatin analogues in neuroendocrine tumors. Anticancer Agents Med Chem 2012; 12:526-42.
01.06.2012Peptide receptor radionuclide therapy with somatostatin analogues in neuroendocrine tumors
01.06.2012Anticancer Agents Med Chem 2012; 12:526-42
Giovacchini Giampiero, Nicolas Guillaume, Forrer Flavio
Radiopeptide imaging and therapy in Europe
Ambrosini V, Fani M, Fanti S, Forrer F, Maecke H. Radiopeptide imaging and therapy in Europe. J Nucl Med 2011; 52 Suppl 2:42S-55S.
01.12.2011Radiopeptide imaging and therapy in Europe
01.12.2011J Nucl Med 2011; 52 Suppl 2:42S-55S
Ambrosini Valentina, Fani Melpomeni, Fanti Stefano, Forrer Flavio, Maecke Helmut R
Bombesin antagonist-based radioligands for translational nuclear imaging of gastrin-releasing peptide receptor-positive tumors
Abiraj K, Mansi R, Tamma M, Fani M, Forrer F, Nicolas G, Cescato R, Reubi J, Maecke H. Bombesin antagonist-based radioligands for translational nuclear imaging of gastrin-releasing peptide receptor-positive tumors. J Nucl Med 2011; 52:1970-8.
11.11.2011Bombesin antagonist-based radioligands for translational nuclear imaging of gastrin-releasing peptide receptor-positive tumors
11.11.2011J Nucl Med 2011; 52:1970-8
Abiraj Keelara, Mansi Rosalba, Tamma Maria-Luisa, Fani Melpomeni, Forrer Flavio, Nicolas Guillaume, Cescato Renzo, Reubi Jean Claude, Maecke Helmut R